QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BEAM

QT54Beam Therapeutics Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
34.14
+1.66+5.11%
OverviewShort InterestFilings
BEAMQT54Beam Therapeutics Inc.·NASDAQ
OverviewShort InterestFilings
34.14+5.11%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.68
Insider Own15.01%
Shs Outstand102.88M
Perf Week16.08%
Market Cap3.34BForward P/E-EPS next Y-4.62Insider Trans0.01%Shs Float-Perf Month29.66%
Enterprise Value3.30BPEG-EPS next Q-1.11Inst Own-Short Float-Perf Quarter35.64%
Income-64825292.00P/S20.37EPS this Y-550.13%Inst Trans-Short Ratio-Perf Half Y27.58%
Sales164.01MP/B2.88EPS next Y-4.56%ROA-4.39%Short Interest-Perf YTD23.16%
Book/sh11.31P/C-EPS next 5Y-ROE-5.89%52W High36.44 -6.31%Perf Year104.80%
Cash/sh11.78P/FCF-EPS past 3/5Y-ROIC-26.15%52W Low15.60 118.85%Perf 3Y-
Dividend Est.-EV/EBITDA-103.16Sales past 3/5Y31.91% -Gross Margin-32.43%Volatility4.80% 4.68%Perf 5Y-
Dividend TTM-EV/Sales20.15EPS Y/Y TTM32.10%Oper. Margin-226.58%ATR (14)2.13Perf 10Y-
Dividend Ex-DateNov 04, 2013Quick Ratio16.99Sales Y/Y TTM156.25%Profit Margin-39.66%RSI (14)61.91Recom2.25
Dividend Gr. 3/5Y-Current Ratio16.99EPS Q/Q26.61%SMA2011.47%Beta2.22Target Price48.00
Payout0.00%Debt/Eq0.22Sales Q/Q357.14%SMA5013.19%Rel Volume1.66Prev Close32.48
Employees393LT Debt/Eq0.23EarningsAug 04SMA20026.46%Avg Volume2.11MPrice34.14
IPO DateFeb 06, 2020Option/ShortYes / YesEPS/Sales Surpr.-4.60% 190.91%Net Debt/EBITDA1.17Volume3,486,450Change5.11%
Analyst Ratings
DateActionAnalystRatingTarget
May-21-26ReiteratedH.C. Wainwright$80
May-13-26ReiteratedTudor Pickering$40 → $39
Feb-25-26ReiteratedRBC CapitalSector Perform$26
Feb-20-26InitiatedCanaccordBuy$74
Jan-21-26ReiteratedTudor Pickering$37 → $41
Jan-07-26ReiteratedUBS$28
Nov-24-25InitiatedEvercore ISIOutperform$35
Oct-09-25InitiatedJefferiesBuy$41
May-07-25ReiteratedGuggenheimBuy$55
Mar-28-25UpgradeB of A SecuritiesNeutral → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue16414064
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A21822368
Gross Profit-53117-304
Selling, General and Administrative Excl. Other115114112
Research and Development416410368
Other Operating Expense-212-23-368
Operating Income-371-384-416
Interest Expense11440
Unusual Expense
———
Non-Operating Income (Expense)-317-347-39
Net Income Before Taxes-65-80-377
Income Taxes000
Consolidated Net Income-65-80-377
Net Income From Continuing Operations-65-80-377
Net Income-65-80-377
EPS (Recurring)-0.64-0.81-4.58
EPS (Basic, Before Extraordinaries)-0.64-0.81-4.58
EPS (Diluted)-0.68-0.81-4.58
EBITDA-32-30-355
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio21.4419.60—
Gross Margin-32.3283.57-475.00
Operating Margin-226.22-274.29-650.00
Net Margin-39.63-57.14-589.06
Shares Outstanding1039982
Market Capitalization3,5162,744—
Operating Lease Expense
———
Insider Trading Volume
$36.71$31.23$25.74$20.25$14.77● Close Price0.00M0.61M1.22M1.83M2.44MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Evans John M.CEOApr 01 '26Sale24.5830,078739,3171,047,205Apr 06 12:00 AM
Simon AmyChief Medical OfficerApr 01 '26Sale24.586,700164,686102,735Apr 06 12:00 AM
Cavanagh Bethany JSVP, Finance and TreasurerApr 01 '26Sale24.583,24279,68851,171Apr 06 12:00 AM
Bellon ChristineChief Legal OfficerApr 01 '26Sale24.585,956146,398109,711Apr 06 12:00 AM
Ciaramella GiuseppePresidentApr 01 '26Sale24.5811,810290,290218,406Apr 06 12:00 AM
Evans John M.CEOMar 31 '26Option Exercise0.6750,00033,5001,011,667Apr 01 12:00 AM
Evans John M.CEOMar 31 '26Sale22.7625,000569,085986,667Apr 01 12:00 AM
Evans John M.CEOMar 30 '26Option Exercise0.6725,00016,75043,672Apr 01 12:00 AM
Evans John M.CEOMar 30 '26Sale22.3725,000559,230986,667Apr 01 12:00 AM
Ciaramella GiuseppePresidentFeb 24 '26Option Exercise17.0070,0001,190,000397,313Feb 26 12:00 AM
Ciaramella GiuseppePresidentFeb 24 '26Sale32.0035,0001,120,042190,216Feb 26 12:00 AM
Evans John M.CEOJan 30 '26Option Exercise0.6750,00033,5001,011,667Feb 02 12:00 AM
Evans John M.CEOJan 30 '26Sale28.3625,000708,946986,667Feb 02 12:00 AM
Evans John M.CEOJan 29 '26Sale29.3825,000734,582986,667Feb 02 12:00 AM
Evans John M.CEOJan 29 '26Option Exercise0.6744,33629,7051,006,003Feb 02 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR